Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Cancer02:18

Cancer

53.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

575
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
575
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiomic analyses delineate human neuroendocrine tumor cell states in relation to normal enteroendocrine cell ontogeny.

The Journal of clinical investigation·2026
Same author

Control of innate olfactory valence by segregated cortical amygdala circuits.

eLife·2026
Same author

Surgical management of pancreatic neuroendocrine tumours.

The British journal of surgery·2026
Same author

Impact of biliary fungal contamination on outcomes after pancreaticoduodenectomy for pancreatic cancer.

Frontiers in oncology·2026
Same author

Surgical management of small intestinal neuroendocrine tumours.

The British journal of surgery·2026
Same author

Variable GLP-1 receptor expression across diverse neuroendocrine neoplasms: implications for incretin therapies.

Endocrine oncology (Bristol, England)·2025

Related Experiment Video

Updated: Dec 18, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.2K

Carcinoid Tumors: Past, Present, and Future.

James R Howe1

  • 1University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242 USA.

Indian Journal of Surgical Oncology
|June 12, 2020
PubMed
Summary

Carcinoid tumors, the most common small bowel tumors, are increasingly diagnosed. These hormone-producing tumors present unique symptoms and characteristics, with ongoing research evolving their natural history and treatment.

Keywords:
CarcinoidCytoreductionLymphadenectomyNeuroendocrineSmall bowel

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

564
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.8K

Related Experiment Videos

Last Updated: Dec 18, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

564
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.8K

Area of Science:

  • Surgical Oncology
  • Endocrinology
  • Gastroenterology

Background:

  • Carcinoid tumors are the most frequent neoplasms encountered in the small bowel.
  • These tumors are characterized by the production of various hormones, leading to distinct clinical manifestations.
  • The increasing frequency of diagnosis highlights their growing clinical significance.

Purpose of the Study:

  • To summarize recent advances in the understanding of carcinoid tumors.
  • To provide an overview of the evolving natural history and treatment strategies for these neoplasms.
  • To consolidate current knowledge for surgeons and clinicians managing these patients.

Main Methods:

  • Review of current literature on carcinoid tumors.
  • Synthesis of data regarding tumor characteristics, hormonal activity, and clinical presentation.
  • Analysis of contemporary treatment modalities and outcomes.

Main Results:

  • Carcinoid tumors exhibit diverse hormonal secretions influencing patient symptoms.
  • Surgical management and therapeutic approaches are continually being refined.
  • Understanding the natural history is crucial for effective patient care.

Conclusions:

  • Carcinoid tumors represent a significant and increasingly recognized clinical challenge.
  • Advances in understanding their biology and treatment are improving patient outcomes.
  • Continued research is essential to further optimize the management of small bowel carcinoid tumors.